SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

Recipharm adds capacity through ViroPharma contract

14-Mar-2012
Last updated the 15-Mar-2012 at 09:37 GMT

Swedish CDMO Recipharm will gain manufacturing capacity through its new production contract with ViroPharma.

Under the deal – which will see Recipharm make commercial supplies of the adrenal insufficiency drug Plenadren – ViroPharma will invest in new tablet manufacturing and active pharmaceutical ingredient (API) coating technology to be installed at the CDMO’s plant in Arsta, Stockholm

The agreement follows Recipharm’s completion of a scale-up contract with original Plenadren developer Sweden-based DuoCort, which was acquired by ViroPharma in November for an upfront payment of $33m (€25m).

Helene Fehrm, General Manager at Recipharm Stockholm told Outsourcing-pharma.com that: “we will be able to use the technology for other customers” although the US drugmaker “retains its status as a customer with the highest priority.”

Key Industry Events

 

Access all events listing

Our events, Events from partners...